Latest Market Studies News

Sky Metals releases a Pre-Feasibility Study confirming Tallebung's robust economics with a 7.3-year mine life, strong cashflows, and rapid capital payback, targeting mid-2028 production.

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

OncoSil Medical has cleared a major regulatory hurdle as its Humanitarian Device Exemption application nears FDA approval, while its TRIPP-FFX trial shows promising results combining OncoSil with standard chemotherapy for pancreatic cancer.

Metals Australia’s new PEA for its Quebec Battery Anode Material Refinery reveals robust economics with a $2.05 billion USD pre-tax NPV and a 25.6% IRR, underpinning plans for a final feasibility study.

AVITA Medical’s Cohealyx-I study interim results show a significant acceleration in skin grafting time for full-thickness wounds, reducing mean time to graft from 33.2 to 13.6 days. The ongoing trial’s promising data could reshape wound care protocols.

Resouro Strategic Metals reports encouraging metallurgical testwork results and progress on the Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project in Brazil, highlighting potential for a globally significant operation.

Metals Australia Ltd is progressing pre-feasibility studies for its Lac Carheil Graphite Project in Quebec, aligning with the province’s new strategy to accelerate critical minerals development. The project’s expanded resource and downstream battery material plans position it well for North American markets.

Asian Battery Metals PLC reports outstanding metallurgical test results from its Oval Cu-Ni-PGE project in Mongolia, confirming high copper recoveries of up to 95% with a simple flotation process and no penalty elements. Nickel concentrate optimization is underway, supporting the project's development trajectory.

EBR Systems has completed the first patient implant in its Totally Leadless CRT (TLC-AU) feasibility study, marking a strategic step toward expanding wireless cardiac resynchronisation therapy for heart failure patients.

EBR Systems has achieved a major commercial milestone with Medicare reimbursement approvals for its wireless cardiac pacing WiSE CRT System, driving a 201% revenue increase in Q3 2025. The company is advancing its Limited Market Release as it scales adoption in the US.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

Lakes Blue Energy marked a pivotal quarter with its ASX reinstatement, a $5.8 million capital raise, and completion of the Wombat-5 well, setting the stage for imminent production testing and resource upgrades.